Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Preferred Dividend Payments (2024 - 2025)

Lucid Diagnostics (LUCD) has disclosed Preferred Dividend Payments for 2 consecutive years, with $3.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Preferred Dividend Payments changed N/A year-over-year to $3.4 million, compared with a TTM value of $12.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $7.5 million, changed N/A over the prior year.
  • Preferred Dividend Payments was $3.4 million for Q2 2025 at Lucid Diagnostics, down from $9.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $9.1 million in Q1 2025 and bottomed at $3.4 million in Q2 2025.